PMID: 5656636Jun 22, 1968Paper

Prostaglandins released by the spleen

Nature
N GilmoreJ H Wyllie

Abstract

No abstract listed.

References

Jul 1, 1966·The American Journal of Physiology·M J Brody
Feb 1, 1968·British Journal of Pharmacology and Chemotherapy·A BennettJ H Wyllie
Dec 2, 1967·Nature·A BennettJ R Vane
Jan 1, 1968·British Journal of Pharmacology and Chemotherapy·B N DaviesP G Withrington
Jan 1, 1968·British Journal of Pharmacology and Chemotherapy·C Bell
Jul 1, 1966·The American Journal of Physiology·P W Ramwell, J E Shaw
Oct 1, 1967·The American Journal of Physiology·F CoceaniL S Wolfe
Jan 1, 1967·British Journal of Pharmacology and Chemotherapy·S M KarimE D Williams
Sep 1, 1953·British Journal of Pharmacology and Chemotherapy·J H GADDUM
Sep 1, 1957·British Journal of Pharmacology and Chemotherapy·J R VANE
Oct 1, 1964·British Journal of Pharmacology and Chemotherapy·D REGOLI, J R VANE
May 1, 1965·Canadian Journal of Physiology and Pharmacology·F COCEANI, L S WOLFE
Jun 1, 1950·British Journal of Pharmacology and Chemotherapy·M MANN, G B WEST

❮ Previous
Next ❯

Citations

Oct 1, 1979·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·W G Unger
Sep 8, 1973·Naunyn-Schmiedeberg's Archives of Pharmacology·B Peskar, G Hertting
Oct 25, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·H Juan
Jul 20, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·U Förstermann, G Hertting
Jan 14, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·A JobkeG Hertting
Mar 31, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·R J Gryglewski
Oct 1, 1973·Die Naturwissenschaften· Pham-Huu-Chanh, M C Nicot-Carthèry
Sep 1, 1979·Biulleten' eksperimental'noĭ biologii i meditsiny·E S GabrielianA G Aĭvazian
Oct 1, 1977·Agents and Actions·R K Türker, Z S Ercan
Sep 1, 1980·Agents and Actions·M Di RosaN Mascolo
Dec 1, 1975·Agents and Actions·F B Ubatuba, S H Ferreira
Jul 1, 1976·Agents and Actions·F B Ubatuba, S H Ferreira
Jan 1, 1986·Agents and Actions·A IalentiM Di Rosa
Dec 1, 1992·Annals of Dyslexia·L K Holt-Ochsner, F R Manis
Mar 7, 2008·Advances in Therapy·Abdullah ErenFeridun Cilli
Dec 1, 1972·Biochemical Pharmacology·O B Henriques, L Allan
Sep 1, 1981·Biochemical Pharmacology·G FolcoE Graström
Feb 15, 1983·Biochemical Pharmacology·A A Abdel-LatifR K Dover
Jan 1, 1973·European Journal of Pharmacology·C Larsson, E Anggård
Jul 1, 1974·European Journal of Pharmacology·E Müller-Schweinitzer
Sep 1, 1976·European Journal of Pharmacology·A G Herman, J R Vane
Feb 1, 1976·European Journal of Pharmacology·V A Alabaster, Y S Bakhle
Oct 1, 1977·European Journal of Pharmacology·G J DustingJ R Vane
Nov 1, 1977·European Journal of Pharmacology·Y S Bakhle, T W Smith
Mar 1, 1979·European Journal of Pharmacology·K M MullaneJ R Vane
Aug 15, 1979·European Journal of Pharmacology·R GreenbergM J Antonaccio
Apr 4, 1980·European Journal of Pharmacology·M F GimenoA L Gimeno
Sep 5, 1980·European Journal of Pharmacology·K M Mullane, S Moncada
Mar 7, 1980·European Journal of Pharmacology·F Al-Ubaidi, Y S Bakhle
Mar 7, 1980·European Journal of Pharmacology·T Hidaka, K U Malik
Jun 19, 1981·European Journal of Pharmacology·C OminiF Berti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.